PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

News | March 05, 2013

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron...

Nuclear Imaging Choosing Wisely Five Questions Testing PET/SPECT Systems
Feature | February 26, 2013

February 26, 2013 — The Society of ...

Technology | February 13, 2013

February 13, 2013 — Nuclear Medicine Information Systems LLC (NMIS) and BioDose LLC have been renamed and rebranded...

PET CT Journal of Nuclear Medicine Nuclear Imaging Clinical Trial Study
News | February 08, 2013

February 8, 2013 — While amyloid imaging may now be most associated with detecting plaques in the brain, it has the...

This SPECT/CT study clearly shows ischemia in the heart.

Feature | November 20, 2012 | Lalitha Ramanna, M.D., FACNM

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon...

Philips Healthcare Ambient Experience RSNA 2012
Technology | November 06, 2012

The Philips Healthcare Ambient Experience integrates architecture, design and enabling technologies, such as dynamic...

News | October 25, 2012

October 25, 2012 — Lantheus Medical Imaging Inc. announced it has extended its contract with Nordion to supply...

GE Healthcare University of Wisconsin Scool of Medicine Imaging
Technology | October 05, 2012

October 5, 2012 — Imagine a place where doctors can tell patients in advance if cancer treatment will work for them...

News | September 12, 2012

September 12, 2012  – Positron Corp. announced that Jubilant DraxImage Inc., a Jubilant Life Sciences company, and...

Feature | August 27, 2012

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master...

Technology | August 21, 2012

August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow...

News | August 20, 2012

August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of...

News | August 14, 2012

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its...

News | August 03, 2012

August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging...

News | July 25, 2012

July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds...

Overlay Init